Article Text

Download PDFPDF
Distance practical course on systematic reviews to support decisions of Brazilian regulatory agency for supplementary healthcare system
  1. Rafael Leite Pacheco1,2,3,
  2. Angela Maria Bagattini1,4,5,
  3. Daniela Vianna Pachito1,6,
  4. Ana Luiza Cabrera Martimbianco2,7,
  5. Fernanda d Athayde Rodrigues5,
  6. Roberta de Fátima Carreira Moreira8,
  7. Rachel Riera1,3
  1. 1 Center of Health Technology Assessment, Hospital Sírio-Libanês, Sao Paulo, São Paulo, Brazil
  2. 2 Departamento de Medicina, Centro Universitário São Camilo, São Paulo, São Paulo, Brazil
  3. 3 Escola Paulista de Medicina, Universidade Federal de São Paulo, Sao Paulo, São Paulo, Brazil
  4. 4 Institute of Tropical Pathology and Public Health, Universidade Federal de Goiás, Goiania, GO, Brazil
  5. 5 Instituto Nacional de Ciência e Tecnologia de Avaliação em Tecnologias em Saúde (INCT/IATS), Porto Alegre, RS, Brazil
  6. 6 Instituto de Desenvolvimento Educacional, Fundação Getúlio Vargas, São Paulo, Brazil
  7. 7 Programa de pos-graduação em saúde e meio ambiente, Universidade Metropolitana de Santos, Santos, SP, Brazil
  8. 8 Departamento de Fisioterapia, Universidade Federal de São Carlos, Sao Carlos, SP, Brazil
  1. Correspondence to Angela Maria Bagattini, Hospital Sírio-Libanês, Sao Paulo, São Paulo 01308-050, Brazil; angelabagattini{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

The healthcare service in Brazil comprises a public and universal system (Sistema Único de Saúde, SUS), but a considerable part of the population (59.7 million) also maintains a private health insurance as a supplementary care.1 The supplementary system is regulated by an autonomous governmental agency, formally Agência Nacional de Saúde Suplementar (ANS), which regulates the relationship between users and health operators and plans, including financial, legal and coverage aspects.

The catalogue of drugs, devices and procedures that should be offered by health plans to their users is updated by ANS every other year for adding, replacing or excluding technologies through a complex process. The process was revisited and has …

View Full Text


  • Twitter @RieraRachel

  • Contributors Conception and design was done by RLP and RR. Data collection was done by RLP, AMB, ALCM, FdAR and RdFCM. Manuscript drafting was done by RLP, RR and AMB. RLP, AMB, DVP, ALCM, FdAR, RdFCM and RR were content revisors. All authors provided final approval.

  • Funding This study was supported by the Brazilian Ministry of Health by the Programa de Apoio ao Desenvolvimento Institucional do Sistema Único de Saúde (PROADI-SUS), led by Hospital Sírio- Libanês, São Paulo, Brazil.

  • Competing interests All the author acted as coordinator, or professor or tutor of the course described.

  • Provenance and peer review Not commissioned; internally peer reviewed.